Breaking News, Financial News

Financial Report: Roche

Pharma sales up 2% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roche FY Revenues: $49.8 billion (+1%) FY Earnings: $10.7 billion (+5%) Comments: Pharmaceutical Division sales were $38.6 billion, up 2%. MabThera/Rituxan sales were $7.3 billion (+9% in local currencies). Herceptin sales were $6.4 billion (+11% lc). Avastin sales were $6.3 billion (+6% lc). Diagnostics Division revenues were flat at $11.2 million. R&D spend was $8.2 billion, up 2%....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters